Nwe Ni Than - Concepedia

Author

Nwe Ni Than

University of Birmingham ORCID

Also Known As

Harpal Randeva, N N Than, N Than, N. N. Than, N. Than, N.N. Than, Nwe Ni (Sophia) Than, Nwe Ni Than, Nwe Than

Publications

896

Citations

H-Index

Concepts

All Affiliations

University of Birmingham NIHR Birmingham Liver Biomedical Research Unit University Hospitals Birmingham NHS Foundation Trust Universität Hamburg University Medical Center Hamburg-Eppendorf

About

Nwe Ni Than is an author at University of Birmingham specializing in immunology, immunotherapy, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	105
2	Allergy Medicine	1	1	105
3	Hepatology	1	1	105
4	Immunology	1	1	105
5	Autoimmune Disease	1	1	105

Nwe Ni Than

Publications

436

Citations

H-Index

Page 1

	Year	Citations
Efficacy of 6-Mercaptopurine as Second-Line Treatment for Patients With Autoimmune Hepatitis and Azathioprine Intolerance Sina Hübener, Ye Htun Oo, Nwe Ni Than, Clinical Gastroenterology and Hepatology Second-line TreatmentAutoimmune DiseaseHepatologyAzathioprine IntoleranceAllergy Medicine	2015	105
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group Nwe Ni Than, James Hodson, Daniel Schmidt-Martin, JHEP Reports	2019	94
Sphingosine-1-Phosphate Prevents Egress of Hematopoietic Stem Cells From Liver to Reduce Fibrosis Andrew King, Diarmaid D. Houlihan, Dean Kavanagh, Gastroenterology	2017	63
Long-term follow-up of patients with difficult to treat type 1 autoimmune hepatitis on Tacrolimus therapy Nwe Ni Than, Christiane Wiegard, Christina Weiler‐Normann, Scandinavian Journal of Gastroenterology	2015	61
Comparing clinical presentations, treatments and outcomes of hepatocellular carcinoma due to hepatitis C and non-alcoholic fatty liver disease Nwe Ni Than, Anwar Ghazanfar, James Hodson, QJM	2016	42
REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC): a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial Andrew King, Darren Barton, Heather Beard, BMJ Open	2015	30
Non-alcoholic fatty liver disease: when to intervene and with what Nwe Ni Than, Philip N. Newsome Clinical Medicine	2015	25
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications Farah Abdelhameed, A.I. Mustafa, Chris Kite, Livers	2025	16

Page 1